Possible paracrine mechanism of insulin-like growth factor-2 in the development of liver metastases from colorectal carcinoma

Cancer

Volumn 85, Issue 1, 1999, Pages 18-25

  Kawamoto, Kazuyuki ^a   Onodera, Hisashi ^a   Kan, Shugen ^a   Kondo, Shohei ^a   Imamura, Masayuki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Colorectal carcinoma; Insulin like growth factor 1 receptor; Insulin like growth factor 2; Liver metastasis; Paracrine mechanism; Proliferating cell nuclear antigen

Indexed keywords

CYCLINE; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADULT; ARTICLE; CANCER CELL; CELL LABELING; CELL PROLIFERATION; CLINICAL ARTICLE; COLORECTAL CARCINOMA; DIAGNOSTIC ACCURACY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER CELL; LIVER METASTASIS; PRIORITY JOURNAL; TUMOR GROWTH;

AGED; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INSULIN-LIKE GROWTH FACTOR II; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTOR, IGF TYPE 1;

EID: 0032893137     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990101)85:1<18::AID-CNCR3>3.0.CO;2-4     Document Type: Article

References (23)

1. Radinsky R, Eliss LM. Molecular determinants in the biology of liver metastasis. Surg Oncol Clin N Am 1996;5:215-29.
2. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889;1:571-3.
3. Radinsky R. Molecular mechanisms for organ-specific colon carcinoma metastasis. Eur J Cancer 1995;31A:1091-5.
4. Long L, Nip J, Brodt P. Paracrine growth stimulation by hepatocyte-derived insulin-like growth factor-1: a regulatory mechanism for carcinoma cells metastatic to the liver. Cancer Res 1994;54:3732-7.
5. Kawamoto K, Onodera H, Kondo S, Kan S, Maetani S, Ikeuti D, et al. Expression of insulin-like growth factor-2 can predict the prognosis of human colorectal cancer patients: correlation with tumor progression, proliferative activity and survival. Oncology 1998;55:242-8.
6. Lambert S, Carlisi A, Collette A, Franchimont P, Gol-Winkler R. Insulin-like growth factor-II in two human colon carcinoma cell lines: gene structure and expression, and protein secretion. Int J Cancer 1992;52:404-8.
7. Han VKM, Lund PK, Lee DC, D'ercole AJ. Expression of somatomedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: identification, characterization, and tissue distribution. J Clin Endocrinol Metabol 1988;66:422-9.
8. Mohan S, Jennings JC, Linkhart TA, Baylink DJ. Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-II. Biochim Biophys Acta 1988;966:44-55.
9. Schoenle EJ, Haselbacher GK, Briner J, Janzer RC, Gammeltoft S, Humbel RE, et al. Elevated concentration of IGF-II in brain tissue from an infant with macrencephaly. J Pediatr 1986;108:737-40.
10. Höppner JWN, Mosselman S, Roholl PJM, Lambrechts C, Slebos RJC, Pagter-Holthuizen PD, et al. Expression of insulin-like growth factor-I and -II genes in human smooth muscle tumours. EMBO J 1988;7:1379-85.
11. Lee AV, Darbre P, King RJB. Processing of insulin-like growth factor-II (IGF-II) by human breast cancer cells. Mol Cell Endocrinol 1994;99:211-20.
12. Cariani E, Lasserre C, Seurin D, Hamelin B, Kemeny F, Franco D, et al. Differential expression of insulin-like growth factor II mRNA in human primary liver cancers, benign liver tumors, and liver cirrhosis. Cancer Res 1988; 48:6844-9.
13. Tricoli JV, Rall LB, Karakousis CP, Herrera L, Petrelli NJ, Bell GI, et al. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res 1986;46:6169-73.
14. Lambert S, Vivario J, Boniver J, Gol-Winkler R. Abnormal expression and structural modification of the insulin-like growth-factor-II gene in human colorectal tumors. Int J Cancer 1990;46:405-10.
15. Zarrilli R, Pignata S, Romano M, Gravina A, Casola S, Bruni CB, et al. Expression of insulin-like growth factor (IGF)-II and IGF-I receptor during proliferation and differentiation of CaCo-2 human colon carcinoma cells. Cell Growth Diff 1994;5:1085-91.
16. Lahm H, Amstad P, Wyniger J, Yilmaz A, Fischer JR, Schreyer M, et al. Blockade of the insulin-like growth-factor-I receptor inhibits growth of human colorectal cancer cells: evidence of a functional IGF-II-mediated autocrine loop. Int J Cancer 1994;58:452-9.
17. Lamonerie T, Lavialle C, Haddada H, Brison O. IGF-2 autocrine stimulation in tumorigenic clones of a human colon-carcinoma cell line. Int J Cancer 1995;61:587-92.
18. Jain S, Filipe MI, Hall PA, Waseem N, Lane DP, Levison DA. Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. J Clin Pathol 1991;44:655-9.
19. Visakorpi T. Proliferative activity determined by DNA flow-cytometory and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma. J Pathol 1992;168:7-13.
20. Hsu S, Huang F, Friedman E. Platelet-derived growth factor-B increases colon cancer cell growth in vivo by a paracrine effect. J Cell Physiol 1995;165:239-45.
21. Gold LI, Saxena B, Mittal KR, Marmor M, Goswami S, Nactigal L, et al. Increased expression of transforming growth factor-β isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action. Cancer Res 1994;54:2347-58.
22. Macaulay VM. Insulin-like growth factors and cancer. Br J Cancer 1992;65:311-20.
23. Long L, Rubin R, Baserga R, Brodt P. Loss of metastatic phenotype in murine carcinoma cells expressing an anti-sense RNA to the insulin-like growth factor receptor. Cancer Res 1995;55:1006-9.